Tuberculosis News and Research

Latest Tuberculosis News and Research

New issue of 'Global Fund News Flash' available

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."

4 Jul 2012

Johnson & Johnson seeking U.S. approval for first new TB drug in more than 4 decades

"Johnson & Johnson [J&J] said Monday that it is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis [TB] in more than four decades," the Associated Press reports, adding, "The experimental drug, called bedaquiline, also would be the first medicine specifically for treating multi-drug resistant tuberculosis."

4 Jul 2012

Indonesia must work to empower women in order to improve maternal health standards

Though Indonesia is "widely seen as a development success story -- indeed, it is sometimes referred to as one of Asia's 'rising powers' ... in the area of maternal health, the successes have been modest and much remains to be done," Andrew Rosser, associate director of the Indo-Pacific Governance Research Centre at the University of Adelaide, writes in an Inside Indonesia opinion piece.

4 Jul 2012

Janssen seeks accelerated FDA approval for bedaquiline to treat MDR-TB

Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

2 Jul 2012

Gates Foundation plans to invest in biotech companies to improve global access to treatments, vaccines for infectious diseases

The Bill & Melinda Gates Foundation "plans to take equity stakes in up to a dozen biotech companies this year, signaling a shift towards a 'venture capital' approach at the world's biggest philanthropic organization" and "marking a further move away from its traditional approach of grant-giving and towards a more business-oriented way to support the development of treatments and vaccines for infectious diseases affecting the world's poor," the Financial Times reports.

29 Jun 2012

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could - paradoxically - shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.

29 Jun 2012

Miriam Hospital receives NIH renewal grant to support growth of Lifespan/Tufts/Brown CFAR

The Miriam Hospital has received an $8.5 million, five-year renewal grant from the National Institutes of Health (NIH) to support the continued growth of the Lifespan/Tufts/Brown Center for AIDS Research (CFAR).

28 Jun 2012

TB research finds body’s own response helps TB bacteria survive

Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children’s Center and the Center for TB Research. Shorter duration of drug therapy is key, researchers say, to increase treatment compliance for the growing global health threat posed by the disease.

28 Jun 2012

Anthera announces results from blisibimod Phase 2b study on SLE

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced results from the Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus.

28 Jun 2012

New type of micromachine can penetrate tissue and overcome cellular barriers

Microscopically small submarines that can swim through our blood to clear out clogged arteries or destroy malignant tumors. This concept may sound utopian, but it isn’t. Various micro- and nanomachines have in fact already been developed.

27 Jun 2012

New FIRS data reveals lack of understanding and concern among public about lung disease

New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a lack of understanding and concern among the public about the world's biggest killer - lung disease, which now claims the lives of almost 4 million people a year.

27 Jun 2012

Success in fighting malaria helping to fuel Africa's economic growth, Reuters reports

Reuters examines how the fight against malaria in Africa is helping to fuel the continent's economic growth. "

22 Jun 2012

UC3M joins European research project on tuberculosis treatments

Scientists at the Carlos III University in Madrid (UC3M) are participating in a European research project designed to study tuberculosis treatments. The objective of the study is to improve diagnostic imaging technology in order to help develop new drugs to treat the disease.

22 Jun 2012

Research funding in sub-Saharan Africa needs to 'reflect true disease burden'

With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, "[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment."

22 Jun 2012

Shanghai Institutes of Preventative Medicine, Gentris sign MOU to advance personalized medicine

Gentris Corporation, a global leader in the application of genomic biomarkers to clinical studies, announced today that it has signed a Memorandum of Understanding with the Shanghai Institutes of Preventative Medicine to advance global personalized medicine.

22 Jun 2012

New issue of 'Global Fund News Flash' available

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the "Global Fund News Flash." The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund's work in Madagascar, and a piece examining "a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries," among other stories.

21 Jun 2012

India emerging as model for improvement in developing countries

In this NDTV opinion piece, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, reflects on his recent trip to India, writing, "During my recent visit, I had a chance to see the latest progress on things that matter a lot to us: on eradicating polio and curtailing the spread of infectious diseases like HIV/AIDS and tuberculosis, for example."

21 Jun 2012

Examining the threat of multi-drug resistant TB in India

The Wall Street Journal reports on a rise of multi-drug resistant tuberculosis (TB) in India, writing, "India's slow response to years of medical warnings now threatens to turn the country into an incubator for a mutant strain of tuberculosis that is proving resistant to all known treatments, raising alarms of a new global health hazard."

21 Jun 2012

VOA News, PlusNews examine tuberculosis in South Africa

Several articles published on Tuesday examine tuberculosis (TB) in South Africa. "According to the World Health Organization (WHO), the country has the highest rate of new TB cases annually," VOA News writes, adding, "Thousands of people in South Africa continue to be infected by a disease that's been virtually eradicated in the developed world."

21 Jun 2012

WHO releases programmatic update on antiretroviral treatment as prevention of HIV, TB

"The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health Organization says," the Center for Global Health Policy's "Science Speaks" blog reports.

20 Jun 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

New issue of 'Global Fund News Flash' available

Johnson & Johnson seeking U.S. approval for first new TB drug in more than 4 decades

Indonesia must work to empower women in order to improve maternal health standards

Janssen seeks accelerated FDA approval for bedaquiline to treat MDR-TB

Gates Foundation plans to invest in biotech companies to improve global access to treatments, vaccines for infectious diseases

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

Miriam Hospital receives NIH renewal grant to support growth of Lifespan/Tufts/Brown CFAR

TB research finds body’s own response helps TB bacteria survive

Anthera announces results from blisibimod Phase 2b study on SLE

New type of micromachine can penetrate tissue and overcome cellular barriers

New FIRS data reveals lack of understanding and concern among public about lung disease

Success in fighting malaria helping to fuel Africa's economic growth, Reuters reports

UC3M joins European research project on tuberculosis treatments

Research funding in sub-Saharan Africa needs to 'reflect true disease burden'

Shanghai Institutes of Preventative Medicine, Gentris sign MOU to advance personalized medicine

New issue of 'Global Fund News Flash' available

India emerging as model for improvement in developing countries

Examining the threat of multi-drug resistant TB in India

VOA News, PlusNews examine tuberculosis in South Africa

WHO releases programmatic update on antiretroviral treatment as prevention of HIV, TB

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in